Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Cancer Management and Research
|
March 14, 2014
Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management
Gazala Khan, Rebecca A Moss, Fadi Braiteh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2008
Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma
Fadi Braiteh, Sharon R Hymes, Sergio A Giralt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2009
Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized Trial
Apostolia-Maria Tsimberidou, Fadi Braiteh, David J Stewart, et al.
Journal of Palliative Medicine
|
November 8, 2007
Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center
Nada Fadul, Ahmed Elsayem, J Lynn Palmer, et al.
Cancer Management and Research
|
May 3, 2017
Comparative effectiveness and resource utilization of <i>nab</i>-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a US community setting
Fadi Braiteh, Manish B Patel, Monika Parisi, et al.
Journal of Palliative Medicine
|
September 7, 2007
Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center
Fadi Braiteh, Badi El Osta, J Lynn Palmer, et al.
Cancer Management and Research
|
February 16, 2018
Comparative effectiveness of early-line <i>nab</i>-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis
Reshma L Mahtani, Monika Parisi, Stefan Glück, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2017
Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial
Vincent Chung, Aaron S Mansfield, Fadi Braiteh, et al.
JCO Precision Oncology
|
February 9, 2022
Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients With Metastatic Cancer With an Unknown or Unclear Diagnosis
Sachdev P Thomas, Lauren E Jacobson, Anthony R Victorio, et al.
Pancreas
|
December 6, 2017
Treatment Patterns and Clinical Outcomes in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated in the Community Practice Setting in the United States
Xiaolong Jiao, Sonia Pulgar, Marley Boyd, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Cancer Management and Research
|
March 14, 2014
Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management
Gazala Khan, Rebecca A Moss, Fadi Braiteh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2008
Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma
Fadi Braiteh, Sharon R Hymes, Sergio A Giralt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2009
Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized Trial
Apostolia-Maria Tsimberidou, Fadi Braiteh, David J Stewart, et al.
Journal of Palliative Medicine
|
November 8, 2007
Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center
Nada Fadul, Ahmed Elsayem, J Lynn Palmer, et al.
Cancer Management and Research
|
May 3, 2017
Comparative effectiveness and resource utilization of <i>nab</i>-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a US community setting
Fadi Braiteh, Manish B Patel, Monika Parisi, et al.
Journal of Palliative Medicine
|
September 7, 2007
Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center
Fadi Braiteh, Badi El Osta, J Lynn Palmer, et al.
Cancer Management and Research
|
February 16, 2018
Comparative effectiveness of early-line <i>nab</i>-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis
Reshma L Mahtani, Monika Parisi, Stefan Glück, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2017
Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial
Vincent Chung, Aaron S Mansfield, Fadi Braiteh, et al.
JCO Precision Oncology
|
February 9, 2022
Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients With Metastatic Cancer With an Unknown or Unclear Diagnosis
Sachdev P Thomas, Lauren E Jacobson, Anthony R Victorio, et al.
Pancreas
|
December 6, 2017
Treatment Patterns and Clinical Outcomes in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated in the Community Practice Setting in the United States
Xiaolong Jiao, Sonia Pulgar, Marley Boyd, et al.
Page
of 7